155 related articles for article (PubMed ID: 38223878)
41. [Neuroendocrine tumors of the lung].
Takei H; Asamura H
Nihon Rinsho; 2004 May; 62(5):877-82. PubMed ID: 15148812
[TBL] [Abstract][Full Text] [Related]
42. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
43. Spectrum of neuroendocrine differentiation in lung cancer cell lines featured by cytomorphology, markers, and their corresponding tumors.
Linnoila RI
J Cell Biochem Suppl; 1996; 24():92-106. PubMed ID: 8806093
[TBL] [Abstract][Full Text] [Related]
44. Combined large cell neuroendocrine carcinoma and spindle cell carcinoma of the lung: Report of a rare entity presenting in fine needle aspiration.
Grosse A; Grosse C
Cytopathology; 2021 Jan; 32(1):132-135. PubMed ID: 32656908
[No Abstract] [Full Text] [Related]
45. Comparison of chemotherapy for unresectable pulmonary high-grade non-small cell neuroendocrine carcinoma and small-cell lung cancer.
Igawa S; Watanabe R; Ito I; Murakami H; Takahashi T; Nakamura Y; Tsuya A; Kaira K; Naito T; Endo M; Yamamoto N; Kameya T
Lung Cancer; 2010 Jun; 68(3):438-45. PubMed ID: 19699548
[TBL] [Abstract][Full Text] [Related]
46. Neuroendocrine neoplasms of the lung: Concepts and terminology.
Wick MR; Marchevsky AM
Semin Diagn Pathol; 2015 Nov; 32(6):445-55. PubMed ID: 26500079
[TBL] [Abstract][Full Text] [Related]
47. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
[TBL] [Abstract][Full Text] [Related]
48. Neuroendocrine tumors of the lung: clinicopathological and molecular features.
Iyoda A; Azuma Y; Sano A
Surg Today; 2020 Dec; 50(12):1578-1584. PubMed ID: 32193632
[TBL] [Abstract][Full Text] [Related]
49. Clinical presentation and evaluation of neuroendocrine tumors of the lung.
Detterbeck FC
Thorac Surg Clin; 2014 Aug; 24(3):267-76. PubMed ID: 25065927
[TBL] [Abstract][Full Text] [Related]
50. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
51. Neuroendocrine differentiation in lung carcinoma.
Addis BJ
Thorax; 1995 Feb; 50(2):113-5. PubMed ID: 7701446
[No Abstract] [Full Text] [Related]
52. [Neuroendocrine tumors of the lung].
Oliaro A; Donati G; Filosso PL; Ruffini E
Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278
[TBL] [Abstract][Full Text] [Related]
53. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.
Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE
Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030
[TBL] [Abstract][Full Text] [Related]
54. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
Yeh YC; Chou TY
J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
[TBL] [Abstract][Full Text] [Related]
55. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
Scoazec JY
Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659
[TBL] [Abstract][Full Text] [Related]
56. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.
Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP
Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848
[TBL] [Abstract][Full Text] [Related]
57. Surgical Principles in the Management of Lung Neuroendocrine Tumors: Open Questions and Controversial Technical Issues.
Brascia D; Marulli G
Curr Treat Options Oncol; 2022 Dec; 23(12):1645-1663. PubMed ID: 36269459
[TBL] [Abstract][Full Text] [Related]
58. [Diagnosis of lung biopsy employing the 2015 WHO criteria and detection of related oncogenic driver mutations].
Fang F; Qiao XB; Yang L; Di J; Hu ST; Liu DG; Lyu N
Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):270-275. PubMed ID: 30955261
[No Abstract] [Full Text] [Related]
59. Neuroendocrine tumors of the lung: an update.
Rekhtman N
Arch Pathol Lab Med; 2010 Nov; 134(11):1628-38. PubMed ID: 21043816
[TBL] [Abstract][Full Text] [Related]
60. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR).
García-Yuste M; Matilla JM; Alvarez-Gago T; Duque JL; Heras F; Cerezal LJ; Ramos G
Ann Thorac Surg; 2000 Jul; 70(1):258-63. PubMed ID: 10921719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
